Featured Articles

Sangamo Therapeutics, Inc. announced that it has executed a global licensing collaboration agreement with Novartis to develop and commercialize gene regulation therapies to address…
Read More...

Pfizer Inc. and BioNTech SE announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the U.S. government’s…
Read More...

Daiichi Sankyo Company, Limited and Gustave Roussy today announced a multi-year, multi-study research collaboration to enrich and further enable the development of DS-1062 and…
Read More...

The inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum successfully concluded in Shanghai on July 17, at which more than 700 authoritative…
Read More...

Gilead Sciences, Inc. announced that it will invest $300 million to acquire a 49.9 percent equity interest in Tizona Therapeutics, Inc., a privately held company developing…
Read More...

Roche and Blueprint Medicines Corporation announced the signing of a licensing and collaboration agreement providing exclusive rights to Roche for global co-development and…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA (guselkumab) for adult patients with active…
Read More...

ProteinQure announces a collaboration with the global biopharmaceutical company AstraZeneca to apply structure-based design to the creation of therapeutic libraries with the aim of…
Read More...

Kymera Therapeutics Inc. announced the company has entered into a multi-program strategic collaboration with Sanofi to develop and commercialize first-in-class protein degrader…
Read More...

Moderna, Inc. and Laboratorios Farmacéuticos Rovi, S.A. announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA vaccine candidate against…
Read More...

Pfizer Inc. announced it has pledged $100 million to the new Antimicrobial Resistance (AMR) Action Fund, which launched today, to help address the significant global public health need…
Read More...

Boehringer Ingelheim and Numab Therapeutics (Numab) announced that they have entered into a research collaboration and worldwide licensing agreement. It will start with two projects…
Read More...

GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s…
Read More...

Sarepta Therapeutics, Inc. announced an agreement with Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare Immunoglobulin G (IgG) mediated diseases, for…
Read More...

Symbiosis Pharmaceutical Services, a specialist provider of pharmaceutical and vaccine development services, has announced it has signed a supply agreement with AstraZeneca for sterile…
Read More...

Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have agreed to expand their existing 2018…
Read More...

Gilead Sciences, Inc. announced that for $275 million the company will acquire a 49.9 percent equity interest in Pionyr Immunotherapeutics Inc., a privately held company developing…
Read More...

Neurocrine Biosciences, Inc. and Takeda Pharmaceutical Company Limited announced a strategic collaboration to develop and commercialize compounds in Takeda’s early-to-mid-stage…
Read More...

Jazz Pharmaceuticals plc announced along with its partner PharmaMar that the U.S. Food and Drug Administration (FDA) approved Zepzelca (lurbinectedin) for the treatment of adult…
Read More...

The U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at…
Read More...